TXNL1: A Potential Drug Target Or Biomarker (G9352)

Target Name: TXNL1

NCBI ID: G9352

TXNL1

TXNL1: A Potential Drug Target Or Biomarker

TXNL1 (HEL-S-114) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the NLRPase family of proteins, which are involved in the regulation of cellular stress responses. TXNL1 has been shown to play a role in the regulation of inflammation and cellular stress, and is Therefore, it is a potential drug target or biomarker in a variety of diseases.

The NLRPase family of proteins is a group of proteins that are characterized by the presence of a nucleotide-binding oligomerization domain (NBD) and a nucleotide-binding oligomerization-like domain (NBO), as well as a transmembrane region. The NBD is a protein-coding region that is involved in the regulation of nucleotide binding, while the NBO is a protein-coding region that is involved in the regulation of oligomerization. The NBD and NBO are connected by a尾-sheet, which is a structural unit that is involved in the regulation of protein structure and function.

TXNL1 is a member of the NLRPase family of proteins and is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a 19.1 kDa protein that has four known isoforms, each of which has a different NBD and NBO composition. The NBD of TXNL1 contains a single nucleotide per arm, while the NBO contains a variable number of nucleotides per arm.

TXNL1 has been shown to play a role in the regulation of cellular stress responses. It has been shown to be involved in the regulation of inflammation, cell survival, and cellular signaling. For example, studies have shown that TXNL1 is involved in the regulation of neuroinflammation, and that it promotes the survival of brain cells under conditions of neurotoxicity. Additionally, studies have shown that TXNL1 is involved in the regulation of cellular signaling, and that it promotes the growth and differentiation of various cell types.

TXNL1 is also a potential drug target or biomarker in a variety of diseases. For example, studies have shown that TXNL1 is involved in the regulation of the immune response, and that it promotes the development of cancer. Additionally, studies have shown that TXNL1 is involved in the regulation of inflammation, and that it contributes to the development of autoimmune diseases. Therefore, TXNL1 is a promising target for the development of new therapies for a variety of diseases.

In conclusion, TXNL1 is a protein that is expressed in various tissues of the body and is involved in the regulation of cellular stress responses. It is a member of the NLRPase family of proteins and has been shown to play a role in the regulation of inflammation , cell survival, and cellular signaling. As a result, it is a potential drug target or biomarker in a variety of diseases. Further research is needed to fully understand the role of TXNL1 in the regulation of cellular stress responses and its potential as a drug target or biomarker.

Protein Name: Thioredoxin Like 1

Functions: Active thioredoxin with a redox potential of about -250 mV

The "TXNL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TXNL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets